Claude Desnuelle

8.5k total citations
140 papers, 3.8k citations indexed

About

Claude Desnuelle is a scholar working on Molecular Biology, Neurology and Genetics. According to data from OpenAlex, Claude Desnuelle has authored 140 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 46 papers in Neurology and 30 papers in Genetics. Recurrent topics in Claude Desnuelle's work include Amyotrophic Lateral Sclerosis Research (27 papers), Neurogenetic and Muscular Disorders Research (27 papers) and Mitochondrial Function and Pathology (24 papers). Claude Desnuelle is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (27 papers), Neurogenetic and Muscular Disorders Research (27 papers) and Mitochondrial Function and Pathology (24 papers). Claude Desnuelle collaborates with scholars based in France, United States and Italy. Claude Desnuelle's co-authors include Sabrina Sacconi, Michel Dib, Alain Favier, G Serratrice, Leonardo Salviati, Catherine Garrel, Véronique Paquis‐Flucklinger, Marie‐Hélène Soriani, Sabine Santucci‐Darmanin and Émilien Delmont and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Neurology.

In The Last Decade

Claude Desnuelle

133 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claude Desnuelle France 37 2.1k 1.0k 709 618 480 140 3.8k
Kunihiro Yoshida Japan 36 2.2k 1.0× 519 0.5× 661 0.9× 462 0.7× 863 1.8× 202 4.5k
Michel Vanasse Canada 29 1.7k 0.8× 347 0.3× 795 1.1× 385 0.6× 243 0.5× 84 3.1k
Yasumasa Ohyagi Japan 36 1.3k 0.6× 1.0k 1.0× 702 1.0× 256 0.4× 1.1k 2.3× 192 3.8k
Alexander G. Rabchevsky United States 42 1.6k 0.8× 907 0.9× 1.3k 1.8× 290 0.5× 588 1.2× 78 5.3k
Giorgio Fanò Italy 30 2.0k 1.0× 517 0.5× 474 0.7× 314 0.5× 1.1k 2.3× 105 4.0k
Richard W. Orrell United Kingdom 36 1.7k 0.8× 2.2k 2.1× 700 1.0× 1.2k 1.9× 688 1.4× 90 4.1k
G Serratrice France 31 933 0.4× 1.5k 1.5× 893 1.3× 201 0.3× 383 0.8× 234 3.4k
Michelangelo Mancuso Italy 41 3.5k 1.6× 1.2k 1.1× 1.1k 1.5× 293 0.5× 902 1.9× 212 5.6k
Shigeki Kuzuhara Japan 35 867 0.4× 2.1k 2.1× 823 1.2× 326 0.5× 910 1.9× 190 3.8k
Nathan Pankratz United States 34 1.7k 0.8× 1.8k 1.7× 991 1.4× 121 0.2× 892 1.9× 112 4.6k

Countries citing papers authored by Claude Desnuelle

Since Specialization
Citations

This map shows the geographic impact of Claude Desnuelle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude Desnuelle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude Desnuelle more than expected).

Fields of papers citing papers by Claude Desnuelle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claude Desnuelle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude Desnuelle. The network helps show where Claude Desnuelle may publish in the future.

Co-authorship network of co-authors of Claude Desnuelle

This figure shows the co-authorship network connecting the top 25 collaborators of Claude Desnuelle. A scholar is included among the top collaborators of Claude Desnuelle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claude Desnuelle. Claude Desnuelle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grapperon, Aude‐Marie, Mohamed Boucékine, David Devos, et al.. (2024). Could the motor unit number index be an early prognostic biomarker for amyotrophic lateral sclerosis?. Clinical Neurophysiology. 163. 47–55.
2.
Pradat, Pierre‐François, E Bernard, Philippe Corcia, et al.. (2020). The French national protocol for Kennedy’s disease (SBMA): consensus diagnostic and management recommendations. Orphanet Journal of Rare Diseases. 15(1). 90–90. 40 indexed citations
3.
Soriani, Marie‐Hélène, et al.. (2017). Brain computer interface with the P300 speller: Usability for disabled people with amyotrophic lateral sclerosis. Annals of Physical and Rehabilitation Medicine. 61(1). 5–11. 87 indexed citations
4.
Trivedi, Jaya, Ans van der Ploeg, Richard J. Barohn, et al.. (2016). Phase 1 Safety and Pharmacokinetics of the Novel Enzyme Replacement Therapy neoGAA in Treatment-Naïve and Alglucosidase Alfa-Treated Late-Onset Pompe Disease Patients (S38.005). Neurology. 86(16_supplement). 1 indexed citations
5.
Amador, Maria del Mar, N. Vandenberghe, Jean‐Philippe Camdessanché, et al.. (2016). Unusual association of amyotrophic lateral sclerosis and myasthenia gravis: A dysregulation of the adaptive immune system?. Neuromuscular Disorders. 26(6). 342–346. 19 indexed citations
6.
Rouleau, Matthieu, et al.. (2015). Modeling Andersen's Syndrome in Human Induced Pluripotent Stem Cells. Stem Cells and Development. 25(2). 151–159. 7 indexed citations
7.
Pradat, Pierre‐François, Edor Kabashi, & Claude Desnuelle. (2015). Deciphering spreading mechanisms in amyotrophic lateral sclerosis. Current Opinion in Neurology. 28(5). 455–461. 17 indexed citations
8.
Sacconi, Sabrina, Leonardo Salviati, & Claude Desnuelle. (2014). Facioscapulohumeral muscular dystrophy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(4). 607–614. 41 indexed citations
10.
Montel, Sébastien, et al.. (2012). Evolution of Quality of Life, Mental Health, and Coping Strategies in Amyotrophic Lateral Sclerosis: A Pilot Study. Journal of Palliative Medicine. 15(11). 1181–1184. 20 indexed citations
11.
Sacconi, Sabrina, et al.. (2012). The Potassium Channel Kir2.1 Activity is Required for Osteoblastogenesis. Biophysical Journal. 102(3). 538a–538a. 1 indexed citations
12.
Colson, Serge S., et al.. (2010). Neuromuscular Electrical Stimulation Training: A Safe and Effective Treatment for Facioscapulohumeral Muscular Dystrophy Patients. Archives of Physical Medicine and Rehabilitation. 91(5). 697–702. 29 indexed citations
14.
Benaïm, Charles, et al.. (2006). Echelles fonctionnelles et évaluation des fonctions motrices dans la Sclérose Latérale Amyotrophique [Functional scales and motor assessment in amyotrophic lateral sclerosis]. Revue Neurologique. 1 indexed citations
15.
Desnuelle, Claude, Sabrina Sacconi, Jean‐Pierre Marolleau, Jérôme Larghero, & Jean‐Thomas Vilquin. (2005). Peut-on envisager une thérapie cellulaire autologue de la dystrophie musculaire facio-scapulo-humérale ?. Bulletin de l Académie Nationale de Médecine. 189(4). 697–714. 2 indexed citations
16.
Sacconi, Sabrina, Eva Trevisson, Francesca Pistollato, et al.. (2005). hCOX18 and hCOX19: Two human genes involved in cytochrome c oxidase assembly. Biochemical and Biophysical Research Communications. 337(3). 832–839. 26 indexed citations
17.
Desnuelle, Claude, Michel Dib, Catherine Garrel, & Alain Favier. (2001). A double-blind, placebo-controlled randomized clinical trial of α-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders. 2(1). 9–18. 206 indexed citations
18.
Paul, Rachel, Claude Desnuelle, Jean Pouget, et al.. (2000). Importance of searching for associated mitochondrial DNA alterations in patients with multiple deletions. European Journal of Human Genetics. 8(5). 331–338. 6 indexed citations
19.
Pisano, P., Alain Durand, E Autret, et al.. (1996). Plasma concentrations and pharmacokinetics of idebenone and its metabolites following single and repeated doses in young patients with mitochondrial encephalomyopathy. European Journal of Clinical Pharmacology. 51(2). 167–169. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026